MUMBAI, India, Aug. 10 -- Intellectual Property India has published a patent application (202647090078 A) filed by Boehringer Ingelheim International Gmbh on July 24, 2026, for Antibodies To Connective Tissue Growth Factor (ctgf) And Uses Thereof.
Inventors include Brunner, Andreas-David; Dittus, Lars; Gupta, Priyanka; Lize, Muriel; Myzithras, Maria Bonatsakis; Rybina, Irina; Sauer, Julia; Skronska-Wasek, Wioletta Anna; and Stahl, Heiko Friedrich.
The application for the patent was published on July 31, 2026, under issue no. 31/2026.
Abstract: The present disclosure generally relates to anti-CTGF (connective tissue growth factor) antibodies or antigen-binding fragments thereof. Exemplary anti-CTGF antibodies disclosed herein address the need for treatments of conditions modulated by CTGF signaling. In some aspects, the anti-CTGF antibodies or antigen-binding fragments thereof are for diagnostic and/or therapeutic use, for example in a subject in need thereof, such as a human.
Disclaimer: Curated by HT Syndication.
